The FDA has approved a vaccine for 2009–2010 seasonal influenza that includes the virus strains most likely to cause the flu in the United States this season. The 2009–2010 influenza vaccine contains an A/Brisbane/59/2007 (H1N1)-like virus, an A/Brisbane/10/2007 (H3N2)-like virus, and B/Brisbane/60/2008-like virus. The seasonal influenza vaccine will not protect against the 2009 H1N1 influenza virus. The six influenza vaccines are: Afluria (from CSL Biotherapies), Fluarix and FluLaval (from GlaxoSmithKline), Fluvirin (from Novartis), Fluzone (from sanofi pasteur) and FluMist (from MedImmune).
Please login or register first to view this content.